Our laboratory has been investigating protein biomarkers for thyroid carcinomas [5–10] and showed that programmed death-ligand 1 (PD-L1) overexpression, predominantly localized in cytoplasm and occasionally in plasma membrane of tumor cells, is a useful prognostic marker for aggressive papillary thyroid cancer and its variants [11]. This evidence concerns the gene CD274 and neoplasm.